Joseph Aracri, DO, Allegheny Health Network, spoke with The American Journal of Managed Care® about preventing respiratory syncytial virus (RSV) through immunoglobulin-based treatments and everyday actions.
Joseph Aracri, DO, system chair of pediatrics with AHN Pediatric Institute and medical director of the Medical Nutrition Clinic, Allegheny Health Network, spoke with The American Journal of Managed Care® about preventing respiratory syncytial virus (RSV) in infants and young children.
Transcript
How are new vaccines changing treatment of RSV in infants and young children?
The treatment for children, for infants, is not a vaccine, it's an immunoglobulin. So what we're doing is actually giving antibodies to the babies when they're born to help prevent significant RSV disease. That is, RSV disease that will end up in the hospital or frequent visits to the pediatrician's office. We really think that this is going to be a game changer for these kids and hopefully keep them well through their first respiratory season.
What are some other things that parents can do to protect their children from severe infection?
Really, RSV is a very contagious virus that goes around every year. Usually, by the time the kid is 2, they've already had 2 infections. The majority of RSV infections are just runny nose, cough, maybe a low-grade fever. In some kids, fewer than 5%, [they] will have trouble breathing and almost like an asthma-like attack that's associated with it. What can you do to prevent it? It's just basically other things you do to prevent colds. You know, making sure you wash your hands before touching your baby. If somebody is sick, don't have them around your baby. Those kinds of things. But really, the virus is so contagious and all over the place, it's very hard to avoid.
Real-World Data Show Sotorasib Effective for NSCLC With KRAS Mutation
May 18th 2024Data from real-world and clinical-trial settings on frontline monotherapy treatment with the KRAS inhibitor sotorasib both show similar progression-free survivals and a high likelihood that the treatment’s efficacy is not affected with dose reduction.
Read More
Health Equity and Access Weekly Roundup: May 18, 2024
May 18th 2024The US Senate hosted a panel addressing physician and health care shortages and efforts to increase minority representation in the medical field. An expert discussed initiatives to prevent senior homelessness. Advocates called for the repeal of the Comstock Act. Regulatory reforms are called for to improve rural cancer patients' access to pharmacies. Research reveals the impact of denials on patient access to immunology treatments.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More